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2-Aminothiophene derivatives are an important class of heterocycles found in seve-
ral biologically active and natural compounds. This class of compounds has demon-
strated a broad spectrum of activities and applications as pharmaceuticals and agroche-
micals, dyes, biodiagnostics, and electronic and optoelectronic devices (1).
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A series of 2-[(arylidene)amino]-cycloalkyl[b]thiophene-3-
-carbonitriles (2a-x) was synthesized by incorporation of
substituted aromatic aldehydes in Gewald adducts (1a-c).
The title compounds were screened for their antifungal
activity against Candida krusei and Criptococcus neoformans
and for their antiproliferative activity against a panel of
3 human cancer cell lines (HT29, NCI H-292 and HEP).
For antiproliferative activity, the partial least squares (PLS)
methodology was applied. Some of the prepared com-
pounds exhibited promising antifungal and proliferati-
ve properties. The most active compounds for antifun-
gal activity were cyclohexyl[b]thiophene derivatives, and
for antiproliferative activity cycloheptyl[b]thiophene deri-
vatives, especially 2-[(1H-indol-2-yl-methylidene)amino]-
-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboni-
trile (2r), which inhibited more than 97 % growth of the
three cell lines. The PLS discriminant analysis (PLS-DA)
applied generated good exploratory and predictive re-
sults and showed that the descriptors having shape char-
acteristics were strongly correlated with the biological
data.
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Substituted 2-aminothiophenes are a class of heterocycles that have attracted a great
deal of research interest due their great usefulness as precursors of molecules with phar-
macological properties. They have been reported to exert antitubercular (2), anti-inflam-
matory (3), antimicrobial (4) and antianxiety (5) properties. A survey of the literature also
reveals that substituted 2-aminothiophenes are potent and selective inhibitors of human
leukocyte elastase (6), kinesin spindle protein (KPS) (7) and adenosine A1 receptor allo-
steric enhancers (8). Antifungal (9) and antitumor (10) properties have also been exten-
sively described, resulting in marketed antifungal agents such as sertaconazole.
The above prompted us to synthesize a new series of 2-[(arylidene)amino]-cycloal-
kyl[b]thiophene-3-carbonitrile derivatives by incorporating different substituted aroma-
tic aldehydes at the 2-amino position of the thiophene ring, thereby affording Schiff ba-
ses. These were screened for their in vitro antifungal and antiproliferative activities. Par-
tial Least Squares discriminant analysis (PLS-DA) was applied, using Pentacle, to the
antiproliferative activity of cycloalkyl[b]thiophene derivatives.
EXPERIMENTAL
All melting points were measured on a Quimis-340.27 apparatus (Quimis, Brazil)
and are uncorrected. IR spectra were recorded using potassium bromide pellets on a
Bruker IFS-66 IR spectrophotometer (Bruker, USA). NMR were recorded on a Unity
Plus-300 MHz-Varian spectrometer (Varian, USA) using tetramethylsilane as internal
standard. Chemical shifts are reported in ppm (d), and coupling constants (J) are repor-
ted in Hz. HRMS were recorded on a Delsi-Nermag R1010C mass spectrometer (Delsi-
-Nermag, France) with 70 eV electron impact. Elemental analyses were performed using
an EA 1110 CHNS-O elemental analyzer (CE instruments, UK). The results were found
to be in accord (± 0.4 %) with the calculated values. All reactions were monitored by
TLC on 0.25 mm silica gel plates (60F254, Merck, Germany) using binary mixtures of hex-
ane/ethyl acetate in different proportions (from 9:1 to 1:1, V/V). Spectral, physical and
analytical data of all newly synthesized compounds are listed in Tables I–III.
General synthesis procedure
2-[(Arylidene)amino]-cycloalkyl[b]thiophene-3-carbonitriles (2a-x). – An equimolar
mixture of 1a-c and substituted aromatic aldehyde in ethanol with 0.5 mL of acetic acid
was stirred under reflux for 2 h and then cooled to room temperature. Water was added
and the solid that precipitated out was filtered under vacuum, washed with water, dried
and recrystallized from absolute ethanol (Scheme 1).
Antifungal activity
The in vitro antifungal activity of synthesized compounds 2a-o, 2r-x was investiga-
tedfor two species of pathogenic fungi: Candida krusei LM08 and Criptococcus neoformans
ICB59. These strains were supplied by the URM Culture Collection of the Department of
Mycology, Department of Pharmaceutical Sciences of the Federal University of Paraíba,
Brazil. Minimum inhibitory concentration (MIC) values were determined by the micro-
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dilution broth method using microdilution plates according to the guidelines of the Na-
tional Committee for Clinical and Laboratory Standards (NCCLS). The MIC for all stra-
ins was set at the lowest concentration of the antifungal agent that completely inhibited
the growth of the organism, as detected by the naked eye when compared to the control
group.
All the strains were stored in mineral oil at 18 °C. The viability test and subsequent
taxonomic confirmation were carried out according to Barnett et al. (12). In order to ob-
tain an inoculum of 2.5 ´ 103 cells mL–1, each strain was cultured in a tube containing 20
mL of Sabouraud dextrose agar plus yeast extract at 35 °C for two days. After this time,
suspensions were prepared in a sterile physiological solution (0.85 %) and mixed in a sha-
ker. The inoculum was adjusted to 90 % transmittance at 530 nm, as measured on a spec-
trophotometer. Stock solutions of tested compounds were freshly prepared in dimethyl
sulfoxide (DMSO), which had no effect on the organism at the concentration studied,
aliquoted, and stored at –20 °C in stock solution at a final concentration of 1024 mg mL–1.
Decimal dilutions of thiophene stock solutions were prepared in free RPMI 1640 cell cul-
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Scheme 1.
ture medium (Sigma, USA) and buffered to pH 7.0 with 0.165 mol L–1 of morpholinopro-
panesulphonic acid (MOPS, Sigma, USA). Miconazole and 5-fluorocitosine were used as
reference drugs for anti-Candida and anti-Cryptococcus activity, respectively, and were tes-
ted under similar conditions. Microdilution plates containing serial dilutions (from 1024
to 1 µg mL–1) of each compound were inoculated with each organism. Each plate in-
cluded a positive control (fungi without any compound), negative control (medium only)
and reference drugs. The microdilution plates were incubated at 35 °C and were read vi-
sually after 24 and 72 h of incubation. All tests were performed in duplicate and the re-
sults were expressed as the arithmetic mean of MIC values obtained in the two trials
(13). The bands established for antifungal activity were: excellent activity (50 to 500 mg
mL–1); moderate activity (600 to 1000 mg mL–1); inactive or poor activity (1000 mg mL–1)
(14).
Antiproliferative activity
All synthesized compounds were selected by the National Cancer Institute (NCI)
Developmental Therapeutic Program for in vitro cell line screening. Antiproliferative as-
says were performed according the US NCI protocol as described elsewhere (15). The
compounds were evaluated in one primary dose (25 mL mL–1) for three human cancer
cell lines: colon carcinoma (HT29), lung cancer (NCI H-292) and laryngeal carcinoma (HEP)
cells. The cells lines were supplied by the Rio de Janeiro Cell Bank of the Federal Univer-
sity of Rio de Janeiro (UFRJ), Brazil.
The cytotoxicity/survival of cells in the presence or absence of the experimental
agent was determined using the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazo-
lium bromide) method, as described previously (16). Cells harvested in the log phase of
growth were counted and seeded in triplicate (105 cells per 100 mL per well) in 96-well
microculture plates in a complete free Dulbecco’s modified eagle’s medium (DMEM).
After 24 h of incubation at 37 °C and 5 % CO2, the cultures were treated with the tested
compounds at a single concentration of 25 mg mL–1 in DMSO (100 mL per well). Each
plate also included a positive control (cells without any compound) and a negative con-
trol (medium only). After 72 h of exposure to the compounds, 25 mL of MTT was added
to each well. After 4 h at 37 °C, the reaction was stopped and the formazan crystals for-
med by MTT metabolism were solubilized by additing 50 mL of DMSO to each well. The
cellular metabolism of MTT was quantified by reading the absorbance of the solubilized
product at 595 nm with a 96-well plate reader attached to a spectrophotometer. Results
for each tested compound were reported as the percentage growth of the treated cells
compared to the untreated control cells. The mean ± SD of three independent experi-
ments for each compound was calculated. The compounds were classified as possessing
no activity (0 % growth inhibition), low activity (up to 30.0 % growth inhibition), moder-
ate activity (between 31.0 % and 70.0 % growth inhibition) and high activity (> 70.0 %
growth inhibition) for each cell line tested.
Computational methods
All compounds were drawn (2D structures) using ChemDraw 8.0. They were im-
ported by the Spartan program for Windows 8.0 and were converted into 3D models.
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These models were minimized using the MM+ method (17) and atomic partial charges
were assigned using the AM1 semiempirical method (18). These methods employed
1000 interactions, 100 cycles of optimization, and 10 conformers of lowest minimum en-
ergy. The selected dihedrals were evaluated by rotation in accordance with the standard
(default) conditions of the program, in which the number of simultaneous variations
was 1 to 8. Acyclic chains were submitted to rotations from 60 to 180o and torsion rings
were in the range of 30 to 120o. Conformational search was applied and the EMIN con-
former was selected and saved in sdf format (19).
The compounds were imported using the Pentacle program and the PLS methodol-
ogy was applied. The Pentacle software, produced by Molecular Discovery (Italy), is a
computational tool for computing alignment-free molecular descriptors, also called
GRid-INDependent descriptors or GRIND (20). The software is based on Molecular In-
teraction Fields and describes the ability of the molecules to interact with other mole-
cules and does not require superimposition of compounds. The Pentacle program uses
the GRID force field to characterize potential polar and hydrophobic interaction sites
around target molecules by water (H2O), hydrophobic (DRY) and carbonyl oxygen (O)
and amide nitrogen (N1) probe.
We calculated a binary free PLS-DA for the three cell lines investigated: HT29, NCI
H-292 and HEP. The PLS-DA is a partial least squares regression of a set (Y) of binary
variables describing the categories of a category variable on a set (X) of predictor vari-
ables. PLS-DA looks for components correlated with the unfolded class while describing
a large number of variations in X, i.e., directions able to discriminate between the clas-
ses. It is a compromise between the usual discriminant analysis and a discriminant analy-
sis of the significant principal components of predictor variables. For the construction of
binary PLS matrices the, compounds which showed cytotoxicity greater than 20 % were
considered active = 1, and the compounds that did not reach 20 % inactive = 0.
RESULTS AND DISCUSSION
Chemistry
2-Amino-cycloalkyl[b]thiophene-3-carbonitriles (1a-c) were first synthesized by the
reaction of malononitrile with a cyclic ketone and elemental sulphur in the presence of
morpholine following the Gewald procedure (9, 10). Treatment of 1a-c with substituted
aromatic aldehydes afforded 2-[(arylidene)amino]-cycloalkyl[b]thiophene-3-carbonitrile
(2a-x). The Schiff bases were prepared in satisfactory yield (except 2q). Compounds 2a-g
and 2j were also previously described in the literature (9).
Chemical structures of all newly synthesized compounds (2h, 2i and 2k-x) were chara-
cterized on the basis of their physical, analytical and spectral data, and were in full agree-
ment with the proposed structures (Tables I–III).
The main vibrational bands of the title compounds are given in Table III. IR spectra
showed absorption bands at about 2960–2911 and 2223–2212 cm–1, characteristic of C-H
and CN stretching vibrations, respectively.
1H NMR and 13C NMR data of the compounds obtained are given in Table II and
are consistent with the proposed structures. 1H NMR spectra did not display signs of 2-
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-aminothiophene protons (NH2), but rather CH=N protons, highlighting the success of the
final synthetic step in obtaining the Schiff bases. Signals of the CH=N protons were ob-
served as a singlet in the 8.02–8.95 ppm region, almost always as the stronger deshiel-
ding signal.
The strongest shielding signals and peaks in 1H NMR and 13C NMR were attributed
to cycloalkyl protons and carbons. These appeared at 1.62–2.99 ppm in 1H NMR, and at
21.8–32.0 ppm in 13C NMR. Further support was obtained from the 13C NMR spectra,
which exhibited resonance at 114.0–115.9 ppm attributed to the CN group.
The HRMS of all synthesized compounds exhibited (M+H)+ molecular ion peaks,
which is in agreement with the molecular formulas. For compounds 2v and 2x, the mo-
lecular ion peaks found were [M+Na]+.
Antifungal activity
All synthesized compounds (except 2p and 2q) were evaluated for their in vitro anti-
fungal activity against Criptococcus neoformans and Candida krusei. The data presented in
Table IV show that the tested compounds more efficiently inhibited the growth of C. neo-
formans than the C. krusei strain. The MIC values ranged from excellent (50–500 mg mL–1)
to moderate (600–1500 mg mL–1) for half of the tested compounds, although none exhibi-
ted greater antifungal activity than the reference drugs 5-fluorocytosine and miconazole.
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2h C17H15BrN2S 144 87 56.83/56.83 7.80/7.77 4.21/4.23
2i C16H13FN2S 93–95 65 67.58/67.55 9.85/9.85 4.61/4.62
2k C23H20N2OS 140–142 92 74.16/74.14 7.52/7.50 5.41/5.43
2l C17H15N3O2S 126 90 62.75/62.71 12.91/12.88 4.65/4.66
2m C18H18N2S 88–90 92 73.43/73.44 9.51/9.48 6.16/6.19
2n C19H20N2S 94–95 84 73.99/73.98 9.08/9.07 6.54/6.54
2o C20H22N2S 93–95 70 74.49/74.48 8.69/8.65 6.88/6.91
2p C20H21N3OS 159–160 74 68.35/68.34 11.96/11.95 6.02/6.03
2q C20H21N3S 211 18 71.61/71.61 12.53/12.51 6.31/6.34
2r C19H17N3S 180–182 90 71.44/71.40 13.15/13.12 5.36/5.40
2s C18H13N3S 200–202 67 71.26/71.25 13.85/13.85 4.32/4.33
2t C19H15N3S 175–177 53 71.90/71.87 13.24/13.21 4.76/4.80
2u C20H17N3S 204–206 79 72.48/72.44 12.68/12.67 5.17/5.19
2v C13H10N2S2 174–175 81 60.43/60.41 10.84/10.80 3.90/3.92
2w C14H12N2S2 123–125 88 61.73/61.70 10.28/10.25 4.44/4.46
2x C15H14N2S2 115–117 76 62.90/62.89 9.78/9.77 4.93/4.95
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Table II. NMR data for 2h, i, k-x
Compd. 1H NMR ( ppm)a 13C NMR ( ppm)a
2h 1.64–1.74 (m, 4H, CH2), 1.84–1.88 (m, 2H, CH2),
2.76–2.81 (m, 4H, CH2), 7.58 (d, 2H, J = 8.7 Hz,
Ar-H), 7.78 (d, 2H, J = 8.7 Hz, Ar-H), 8.34 (s, 1H,
CH=N)
157.1, 140.3, 136.7, 133.9, 132.1,
130.5, 126.8, 114.9, 109.7, 31.9,
30.6, 29.1, 27.7, 27.0
2i 1.84–1.90 (m, 4H, CH2), 2.63–2.70 (m, 4H, CH2),
7.12 (d, 2H, J = 8.7 Hz, Ar-H), 7.91 (d, 2H, J = 8.7
Hz, Ar-H), 8.36 (s, 1H, CH=N)
166.8, 163.5, 159.4, 157.3, 135.1,
132.5, 131.5, 131.4, 116.2, 115.9,
114.4, 107.0, 25.1, 24.2, 23.0,
21.9
2k 1.73–1.89 (m, 4H, CH2), 2.62–2.69 (m, 4H, CH2),
5.12 (s, 2H, OCH2), 7.03 (d, 2H, J = 8.7 Hz, Ar-H),
7.34–7.46 (m, 5H, Ar-H), 7.87 (d, 2H, J = 8.7 Hz,
Ar-H), 8.32
(s, 1H, CH=N)
162.1, 160.4, 158.2, 136.0, 134.7,
131.5, 131.3, 128.6, 128.1, 128.1,
127.4, 115.1, 114.6, 105.8, 70.0,
25.0, 24.2, 23.0, 21.9
2l 1.66–1.75 (m, 4H, CH2), 1.85–1.89 (m, 2H, CH2),
2.79–2.82 (m, 4H, CH2), 8.06 (d, 2H, J = 8.7 Hz,
Ar-H), 8.28 (d, 2H, J = 8.7 Hz, Ar-H), 8.43 (s, 1H,
CH=N)
155.8, 155.0, 149.3, 140.9, 140.4,
138.6, 129.6, 123.9, 114.5, 111.4,
31.8, 30.7, 29.0, 27.6, 26.9
2m 1.69 (m, 4H, CH2), 1.86 (m, 2H, CH2), 2.41 (s, 3H,
CH3), 2.78 (m, 4H, CH2), 7.25 (d, 2H, J = 8.1 Hz,
Ar-H), 7.81 (d, 2H, J = 8.1 Hz, Ar-H), 8.38 (s, 1H,
CH=N)
158.8, 158.1, 143.0, 139.9, 135.7,
132.5, 129.5, 129.3, 115.0, 108.7,
31.9, 30.5, 29.1, 27.7, 27.1, 21.7
2n 1.26 (t, 3H, J = 7.5 Hz, CH3), 1.64–1.74 (m, 4H, CH2),
1.84–1.88 (m, 2H, CH2), 2.73 (q, 2H, J = 7.5 Hz,
CH2), 2.75–2.81 (m, 4H, CH2), 7.28 (d, 2H, J = 8.1
Hz, Ar-H), 7.84 (d, 2H, J = 8.1 Hz, Ar-H), 8.39 (s,
1H, CH=N)
158.8, 158.1, 149.3, 139.9, 135.7,
132.7, 129.5, 128.4, 115.0, 108.7,
31.9, 30.5, 29.1, 29.0, 27.8, 27.1,
15.2
2o 1.72 (d, 6H, J = 6.9 Hz, CH3), 1.63–1.73 (m, 4H,
CH2), 1.83–1.91 (m, 2H, CH2), 2.75–2.81 (m, 4H,
CH2), 2.96 (d, 1H, J = 6.9 Hz, CH), 7.31 (d, 2H,
J = 8.1 Hz, Ar-H), 7.84 (d, 2H, J = 8.1 Hz, Ar-H),
8.38 (s, 1H, CH=N)
158.7, 158.1, 153.8, 139.9, 135.6,
132.8, 129.4, 126.9, 115.0, 108.7,
34.2, 31.9, 30.5, 29.0, 27.7, 27.0,
23.6
2p 1.80–1.88 (m, 4H, CH2), 2.61–2.67 (m, 4H, CH2),
3.30
(t, 4H, J = 4.8 Hz, NCH2), 3.84 (t, 4H, J = 4.8 Hz,
OCH2), 6.88 (d, 2H, J = 9 Hz, Ar-H), 7.80 (d, 2H,
J = 9 Hz, Ar-H), 8.26 (s, 1H, CH=N)
161.1, 158.3, 153.7, 134.5, 131.1,
130.8, 125.6, 114.9, 113.9, 105.0,
66.4, 47.4, 25.0, 24.2, 23.0, 21.9
2q 1.85 (m, 4H, CH2), 2.07 (m, 4H, CH2), 2.66 (m, 4H,
CH2), 3.43 (m, 4H, CH2), 6.62 (d, 2H, J = 8.4 Hz,
Ar-H), 7.94 (d, 2H, J = 8.4 Hz, Ar-H), 8.30 (s, 1H,
CH=N)
198.3, 190.2, 158.3, 151.6, 134.5,
133.1, 115.0, 112.3, 111.2, 102.8,
48.0, 47.6, 25.4, 25.3, 24.9, 24.3,
23.1, 22.0
2r 1.65–1.72 (m, 4H, CH2), 1.84–1.88 (m, 2H, CH2),
2.75–2.82 (m, 4H, CH2), 7.29–7.42 (m, 4H, Ar-H),
7.67 (d, 1H, J = 3 Hz, Ar-H), 8.60 (s, 1H, CH=N)
160.5, 153.4, 139.3, 136.9, 133.5,
132.1, 124.8, 124.2, 123.0, 122.7,
116.0, 115.7, 111.3, 106.7, 32.0,
30.5, 29.1, 27.9, 27.2
Compounds 2t and 2u, with MIC values of 64 mg mL–1, and compounds 2d, 2g, 2j,
2k, 2m, 2o and 2v with MIC values of 128 mg mL–1, exhibited excellent antifungal activity
against Criptococcus neoformans. Other tested compounds were inactive, or showed mode-
rate activity (2a). The most active compounds for anti-Cryptococcus activity were 2t and
2u, which have in common the presence of a quinoline moiety linked to the 2-amino po-
sition of the thiophene ring. This result corroborates the data of Boateng and collabora-
tors (21) for a series of benzothieno[3,2-b]quinoline derivatives.
The compounds showed moderate activity against C. krusei. Compounds 2i, 2k and
2t were the most active (MIC = 512 mg mL–1), followed by compounds 2a, 2g, 2j, 2r and
2s (MIC values at 1024 mg mL–1).
The present study also confirmed that the presence of the cyclohexyl ring linked to
the C-4 and C-5 position of the thiophene ring, as found in compounds 2d, 2g, 2i-k and
2t, increases antifungal activity. The cyclopentyl (2a, 2s and 2v) and cycloheptyl (2l-o and
2r) derivatives displayed similar antifungal activity profiles and were, generally, two to
four times less active than the cyclohexyl derivatives (9).
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Table II. continued
2s 2.48 (q, 2H, J = 7.6 Hz, CH2), 2.91 (t, 2H, J = 7.6 Hz,
CH2), 2.99 (t, 2H, J = 7.6 Hz, CH2), 7.79 (t, 1H,
J = 7.6 Hz, Ar-H), 7.87 (t, 1H, J = 7.6 Hz, Ar-H),
8.08 (d, 1H, J = 4.8 Hz, Ar-H), 8.40 (d, 1H, J = 8.4
Hz, Ar-H), 8.95 (d, 1H, J = 8.4 Hz, Ar-H), 8.02 (s,
1H, CH=N), 9.03 (d, 1H, J = 4.8 Hz, Ar-H)
163.5, 154.3, 150.0, 149.0, 145.3,
140.1, 137.1, 130.2, 129.7, 128.3,
125.2, 123.9, 122.1, 114.3, 104.7,
30.2, 28.0, 27.3
2t 1.82–1.88 (m, 4H, CH2), 2.65–2.74 (m, 4H, CH2),
7.91 (d, 2H, J = 6 Hz, Ar-H), 8.90 (t, 2H, J = 11.2 Hz,
Ar-H), 8.95 (s, 1H, CH=N), 9.02 (d, 2H, J = 6 Hz,
Ar-H)
158.4, 155.5, 150.0, 149.0, 137.1,
135.8, 134.8, 130.2, 129.7, 128.2,
125.2, 123.9, 122.1, 114.0, 109.2,
25.3, 24.2, 22.9, 21.8
2u 1.69–1.72 (m, 4H, CH2), 1.88 (m, 2H, CH2), 2.79–2.82
(m, 4H, CH2), 7.66–7.79 (m, 2H, Ar-H), 7.84 (d, 1H,
J = 8.4 Hz, Ar-H), 8.17 (d, 1H, J = 4.5 Hz, Ar-H),
8.90 (d, 1H, J = 8.4 Hz, Ar-H), 8.93 (s, 1H, CH=N),
9.00 (d, 1H, J = 4.5 Hz, Ar-H)
156.3, 155.1, 149.8, 148.8, 140.8,
138.7, 137.2, 130.0, 129.7, 128.2,
125.2, 123.9, 122.0, 114.5, 111.4,
31.8, 30.7, 29.0, 27.6, 26.9
2v 2.36–2.45 (m, 2H, CH2), 2.80–2.92 (m, 4H, CH2),
6.81 (dd, 1H, J = 1.5, 3.6 Hz, Ar-H), 7.11 (d, 1H,
J = 3.6 Hz, Ar-H), 7.64 (d, 1H, J = 1.5 Hz, Ar-H),
8.25 (s, 1H, CH=N)
164.9, 151.2, 146.9, 145.2, 144.8,
137.4, 118.0, 114.7, 112.9, 101.6,
30.1, 28.1, 27.2
2w 1.82–1.91 (m, 4H, CH2), 2.63–2.69 (m, 4H, CH2),
6.58 (dd, 1H, J = 1.5, 3.3 Hz, Ar-H), 7.11 (d, 1H,
J = 3.3 Hz, Ar-H), 7.65 (d, 1H, J = 1.5 Hz, Ar-H),
8.23 (s, 1H, CH=N)
159.7, 151.3, 146.9, 146.3, 135.3,
132.3, 117.8, 114.3, 112.9, 106.1,
25.1, 24.2, 22.9, 21.9
2x 1.62–1.72 (m, 4H, CH2), 1.82–1.86 (m, 2H, CH2),
2.74–2.79 (m, 4H, CH2), 6.57 (dd, 1H, J = 1.5, 3.6 Hz,
Ar-H), 7.10 (d, 1H, J = 3.6 Hz, Ar-H), 7.64 (d, 1H, J
= 1.5 Hz, Ar-H), 8.23 (s, 1H, CH=N)
157.7, 151.2, 146.8, 146.1, 140.3,
136.0, 117.7, 114.9, 112.8, 108.4,
31.9, 30.4, 29.1, 27.7, 27.0
a CDCl3
Antiproliferative activity
Table V summarizes the in vitro antiproliferative effects of cycloalkyl[b]thiophene
derivatives 2a-x against the three human cancer cell lines. Compounds 2a, 2c, 2f-g, 2k-l,
2p-q and 2s-v exhibited antiproliferative activity below the concentration of 25 mg mL–1.
The results indicate that the size of the cycloalkyl ring coupled at the C-4 and C-5
position of the thiophene ring is essential for antiproliferative activity. Increasing the si-
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ze of the cycloalkyl ring helps increase the capacity to inhibit cell growth. Cycloheptyl
derivatives 2r, 2n, 2o and 2x were thus the most active compounds, while all cyclopen-
thyl derivatives were inactive compounds.
The antiproliferative activity of the compounds was greater against the HEP cells
compared to the other two cell lines, as can be seen in compounds 2i, 2n, 2o and 2x with
inhibition of 95.4, 57.3, 71.0 and 52.6 %, respectively. The most active cycloalkyl[b]thio-
phene compound identified in this study was 2r, which inhibited the growth of HT29,
NCI H-292 and HEP cancer cell lines by 100.0, 100.0 and 97.5 %, respectively.
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Table IV. Antifungal activity of the synthesized compounds, miconazole and 5-fluorocitosine
Compd.a
MIC (mg mL–1)


























NT – Not tested
a Solvent: DMSO
Cyclohepthyl[b]thiophene derivatives also demonstrated that the size of the alkyl
group in the para position of the benzylidene moiety seemed to be important for anti-
proliferative activity. In this context, a comparison of substituent effects revealed that
the replacement of i-propyl (2o) by an ethyl (2n) group resulted in a slight reduction in
antitumor activity (reduction of 71.0 to 57.3 % for the HEP cell, and of 45.7 to 42.5 % for
the NCI H-292 cell), and the replacement of ethyl (2n) by a methyl (2m) group resulted
in a substantial loss of activity (reduction of 57.3 to 22.1 % for the HEP cell, 42.5 to 25.8 %
for the NCI H-292 cell and 61.6 to 11.0 % for the HT29 cell).
Another structural feature that can be associated with complete loss of activity in
these derivatives is the presence of bulky or large arylidenes linked to the 2-amino posi-
tion, as can be seen in compounds which have a quinoline moiety (2s, 2t and 2u), and in
compounds 2k, 2p and 2q, which represent 4-benzyloxy-benzylidene, 4-morpholinyl-ben-
zylidene and 4-pyrrolidinyl-benzylidene, respectively.
Computational methods
The goal of PLS regression is to provide a dimension reduction strategy in a situa-
tion where we want to relate a set of response variables Y to a set of predictor variables
X. The PLS-DA is a PLS regression where Y is a set of binary variables describing the ef-
fects of a category variable on X; i.e., the number of dependent, or response, variables is
equal to the number of categories. The best way to extract information from the PLS-DA
is graphically, by plotting the obtained matrices.
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Table V. Antiproliferative activity of the synthesized compounds
Compd.a
Inhibition (%)b,c
HT29 NCI H-292 HEP
2b 11.1 ± 2.7 30.4 ± 1.1 20.8 ± 6.4
2d 24.9 ± 3.8 24.2 ± 5.5 1.6 ± 1.0
2e 0.0 ± 0.0 29.5 ± 3.4 0.0 ± 3.1
2h 11.3 ± 4.8 23.5 ± 1.2 11.3 ± 0.4
2i 53.7 ± 1.9 50.9 ± 4.0 95.4 ± 0.0
2j 4.9 ± 0.6 18.4 ± 0.2 3.7 ± 4.8
2m 11.0 ± 0.6 25.8 ± 1.1 22.1 ± 0.5
2n 61.6 ± 2.0 42.5 ± 2.7 57.3 ± 5.0
2o 28.9 ± 1,5 45.7 ± 3.3 71.0 ± 3.9
2r 100.0 ± 0.5 100.0 ± 0.0 97.5 ± 2.5
2w 34.7 ± 0.7 33.9 ± 3.8 24.1 ± 2.7
2x 25.0 ± 2.0 27.9 ± 2.7 52.6 ± 2.9
a Solvent: DMSO
b 25 mg mL–1
c Mean ± SD, n = 3.
PLS-DA was applied in this study to improve the results obtained by the classic im-
age analysis and to identify the significant spots responsible for the differences in anti-
proliferative activity against the three cell lines, which were similar to each other. The
models presented the following statistical indices:
– R2 ~ 0.80 – coefficient of determination, the squared multiple correlation coefficient,
which is the total variance of the response explained by a regression model;
– SDEP ~ 0.70 – standard deviation error of prediction, also known as standard er-
ror in prediction SEP or PSE, which is the function of the predictive residual sum
of squares;
– Q2 ~ 0.60 – predictive ability of the model.
A large difference was observed between active (triangle up) and inactive (triangle
down) compounds for the three cell lines (Fig. 1). This graph plots X-scores (T) against
Y-scores (U). It provides a clear idea of the correlation between the X’s and the Y’s ob-
tained in the model for each of the LVs. LVs are linear combinations of the original X-
-variables.
The variables highlighted in the studies with the three cell lines differ only by Ang-
stroms but showed that hydrogen bond acceptor regions were characteristic of the active
compounds. The plot weight, obtained in the study with the NCI H-292 cell line, reflects
the behavior observed in all investigations (Fig. 2). Active compounds showed greater
interactions between the probes DRY-DRY, N1-N1 and DRY-N1.
The most active compound (2r) was the only one that exhibited an O-N1 interaction
(represented by the variable VAR246) (triangle up). In Fig. 3 this variable corresponds to an
interaction between 4.40 and 4.80 Å, and characterizes a hydrogen bond acceptor region.
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Fig. 1. Plot scores obtained from PLS-DA, distribution and separation of the set by the best model.
Active (triangle up) and inactive (triangle down) compounds against the investigated cell lines: a)
HT 29 cell line, b) NCI H-292 cell line, and c) HEP cell line.
CONCLUSIONS
In short, novel thiophene derivatives substituted with an arylidene moiety were syn-
thesized, characterized on the basis of their physical, analytical, and spectral data, and
preliminarily evaluated for their in vitro antifungal and antiproliferative properties.
Antifungal studies revealed that the results for the antifungal activity of cycloalkyl-
[b]thiophene derivatives ranged from excellent to moderate and that the most promising
compounds were those that had a cyclohexyl ring linked to the thiophene ring (2d, 2g,
2i-k and 2t).
The results for antiproliferative activity indicate that the most active compounds are
cycloheptyl[b]thiophene derivatives, especially 2-[(1H-indol-2-yl-methylidene)amino]-
5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carbonitrile (2r).
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Fig. 2. Plot weight obtained with the NCI H-292 cell line, selecting the active compounds. Greater
intensity and number of positive influence of the variables are generated on the interaction of pro-
bes DRY-DRY, N1-N1 and DRY-N1 in active compounds.
Fig. 3. Disclosure of O-N1 interaction, VAR 246, in the most active compound (2r) – (triangle up).
The chemometric tool (PLS-DA) applied in this study generated good exploratory
and predictive results. The behavior of the binary free PLS-DAwas similar for the three
human cancer cell lines studied. The descriptors having shape characteristics were
strongly correlated with the biological data. Higher weight variables highlight the inter-
actions between the DRY-DRY N1-N1, DRY-N1 probes. Hydrogen bond acceptor regions
are characteristic of active compounds and the presence of O-N1 interaction, as found in
2r, increased the antitumor activity.
Finally, it can be concluded that cycloalkyl[b]thiophene derivatives could be conside-
red promising compounds for the discovery of new antitumor agents. Further investiga-
tion of the mode of action at molecular level needs to be carried out, and more extensive
studies are needed to determine additional physicochemical and biological parameters in
order to provide a deeper insight into the SAR and to optimize the efficacy and safety of
this series of compounds.
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S A @ E T A K
Preliminarno ispitivanje antimikotskog i citotoksi~nog djelovanja
derivata cikloalkil[b]tiofena PLS-DA analizom
BEATRIZ C. C. SOUZA, TIAGO B. DE OLIVEIRA, THIAGO M. AQUINO, MARIA C. A. DE LIMA, IVAN R. PITTA,
SUELY L. GALDINO, EDELTRUDES O. LIMA, TERESINHA GONÇALVES-SILVA, GARDÊNIA C. G. MILITÃO,
LUCIANA SCOTTI, MARCUS T. SCOTTI i FRANCISCO J. B. MENDONÇA Jr.
Koriste}i supstituirane aromatske aldehide u Gewaldovim aduktima 1a-c sintetizi-
rani su derivati 2-[(ariliden)amino]-cikloalkil[b]tiofen-3-karbonitrila (2a-x). Ispitano je an-
timikotsko djelovanje tih spojeva na gljivice Candida krusei i Criptococcus neoformans te
antiproliferativno djelovanje na tri humane tumorske stani~ne linije (HT29, NCI H-292 i
HEP). Za antiproliferativno djelovanje primijenjena je metoda parcijalnih najmanjih kvad-
rata (PLS) koriste}i softverski program Pentacle. Neki od ispitanih spojeva pokazuju obe-
}avaju}e antimikotsko i antiproliferativno djelovanje. Najja~e antimikotsko djelovanje imaju
cikloheksil[b]tiofen derivati, a najja~e antiproliferativno djelovanje cikloheptil[b]tiofen de-
rivati, posebice 2-[(1H-indol-2-il-metiliden)amino]-5,6,7,8-tetrahidro-4H-ciklohepta[b]tiofen-
-3-karbonitril (2r), koji inhibira vi{e od 97 % rast svih triju ispitivanih stani~nih linija.
Primijenjena PLS diskriminiraju}a analiza dala je dobre istra`iva~ke i prognosti~ke re-
zultate i pokazala da deskriptori dobro koreliraju s biolo{kim rezultatima.
Klju~ne rije~i: cikloalkil[b]tiofen derivati, antimikotsko djelovanje, antiproliferativno djelovanje,
PLS-DA metoda, program Pentacle
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